Paul W. Hoelscher
2016
In 2016, Paul W. Hoelscher earned a total compensation of $904K as Executive Vice President, Chief Financial Officer at Horizon Pharma, a 95% decrease compared to previous year.
Compensation breakdown
| Bonus | $1,000 |
|---|---|
| Non-Equity Incentive Plan | $269,250 |
| Salary | $500,000 |
| Other | $133,764 |
| Total | $904,014 |
Hoelscher received $500K in salary, accounting for 55% of the total pay in 2016.
Hoelscher also received $1K in bonus, $269.3K in non-equity incentive plan and $133.8K in other compensation.
Rankings
In 2016, Paul W. Hoelscher's compensation ranked 8,724th out of 14,075 executives tracked by ExecPay. In other words, Hoelscher earned more than 38.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,724 out of 14,075 | 38th |
Division Manufacturing | 3,370 out of 5,489 | 39th |
Major group Chemicals And Allied Products | 1,146 out of 1,895 | 40th |
Industry group Drugs | 899 out of 1,538 | 42nd |
Industry Pharmaceutical Preparations | 716 out of 1,176 | 39th |
Source: SEC filing on April 3, 2017.
Hoelscher's colleagues
We found four more compensation records of executives who worked with Paul W. Hoelscher at Horizon Pharma in 2016.
News
Horizon Pharma CEO Timothy Walbert's 2021 pay slips 1% to $21M
March 17, 2022
Horizon Pharma CEO Timothy Walbert's 2020 pay jumps 56% to $22M
March 17, 2021
Horizon Pharma CEO Timothy Walbert's 2019 pay slips 17% to $14M
March 18, 2020
Horizon Pharma CEO Timothy Walbert's 2018 pay jumps 617% to $17M
April 8, 2019